The Role of Smoking Cessation in Vascular Disease Management
May 14, 2026 - 16:54
Radio and PodcastLive Radio & Podcasts
Health
SURPASS-CVOT and the Case for Dual Incretin Therapy
Luke Laffin, MD, and Steven Nissen, MD, discuss findings from SURPASS-CVOT, including a secondary analysis evaluating broader cardiovascular and renal outcomes with dual GLP-1 and GIP agonist therapy compared with a firs...
About This Episode
SURPASS-CVOT and the Case for Dual Incretin Therapy is an episode from Cardiac Consult: A Cleveland Clinic Podcast for Healthcare Professionals by Cleveland Clinic Heart & Vascular Institute. Luke Laffin, MD, and Steven Nissen, MD, discuss...
Podcast
This episode belongs to Cardiac Consult: A Cleveland Clinic Podcast for Healthcare Professionals.
Listen Online
Use the player on this page to stream the episode online.
Episode Details
Published Apr 9, 2026, 11:18 long, audio available.
Related Episodes
Continue listening to more episodes from Cardiac Consult: A Cleveland Clinic Podcast for Healthcare Professionals.
Cardiac Surgical Support for High‑Risk Lead Extraction
Apr 30, 2026 - 17:38
Diagnosis and Management of Pericarditis
Apr 28, 2026 - 16:42
Integrating PFA Into Your Clinical Practice
Apr 16, 2026 - 27:29
Monthly Therapy for Hypertension: Insights From the Phase II KARDINAL Trial
Apr 2, 2026 - 10:34
Advancing Vascular Surgery Care Through Clinical Trials
Mar 26, 2026 - 16:45
Aortic Valve Repair for Aortic Regurgitation
Mar 19, 2026 - 38:25
Questions About This Episode
What is SURPASS-CVOT and the Case for Dual Incretin Therapy about?
Luke Laffin, MD, and Steven Nissen, MD, discuss findings from SURPASS-CVOT, including a secondary analysis evaluating broader cardiovascular and renal outcomes with dual GLP-1 and GIP agonist therapy compared with a first-generation GLP-1 agent. The conversation examines outcomes of the therapy on all-cause mortality and the clinical implications for treating patients with diabetes and high cardiovascular risk. View current clinical trials. Looking to refer a patient? Please reach out to our Physician Referral team Mon. - Fri., 8 a.m. - 5 p.m. (ET) at 855.751.2469.
Where can I listen to SURPASS-CVOT and the Case for Dual Incretin Therapy?
You can listen to SURPASS-CVOT and the Case for Dual Incretin Therapy online on Radio and Podcast. Open the player on this page to stream the available audio.
Which podcast is SURPASS-CVOT and the Case for Dual Incretin Therapy from?
SURPASS-CVOT and the Case for Dual Incretin Therapy is an episode from Cardiac Consult: A Cleveland Clinic Podcast for Healthcare Professionals by Cleveland Clinic Heart & Vascular Institute.
How long is this episode?
This episode is 11:18 long.
When was this episode published?
This episode was published on Apr 9, 2026.
Can I save SURPASS-CVOT and the Case for Dual Incretin Therapy for later?
Yes. Use the heart button on the episode page to add it to your favorite episodes list.
Are there related episodes from Cardiac Consult: A Cleveland Clinic Podcast for Healthcare Professionals?
Yes. This page shows related episodes from Cardiac Consult: A Cleveland Clinic Podcast for Healthcare Professionals when more episodes are available from the podcast feed.
Quick Answers About This Episode
Where can I listen to SURPASS-CVOT and the Case for Dual Incretin Therapy?
You can listen to SURPASS-CVOT and the Case for Dual Incretin Therapy on this page when the episode audio is available from the podcast feed.
Which podcast is this episode from?
SURPASS-CVOT and the Case for Dual Incretin Therapy is from Cardiac Consult: A Cleveland Clinic Podcast for Healthcare Professionals by Cleveland Clinic Heart & Vascular Institute.
What are the episode details?
Published Apr 9, 2026 and 11:18 long